Supplements Source

Omega-3 vs. Placebo Secondary OutcomesReduced
Riskp Heart Attack28% p=0.002) Major CVD event (heart attack, stroke,
or death from cardiovascular cause) Fish consumption <1.5 servings/wk19% p=0.03) African Americans with <1.5 servings of fish/wk39% p=0.049) Secondary Outcomes - Subgroup Analyses
Heart Attack African Americans77% p=<0.0001) African Americans with diabetes94% p=0.005) African Americans with 1 cardiovascular risk factor72% p=0.047) African Americans with 2+ cardiovascular risk factors84% p=0.001) Fish consumption <1.5 servings/wk40% p=0.0007) Non-Hispanic Caucasians with <1.5 servings of fish/wk29% p=0.04) African Americans with <1.5 servings of fish/wk77% p=0.003) African Americans with ≥1.5 servings of fish/wk79% p=0.01) Age <66.7 years (median age)40% p=0.005) Males28% p=0.02) Non-current Smokers21% p=0.04) Current Smokers62% p=0.02) Medication-treated diabetes60% p=0.0003) Medication-treated hypertension42% p=0.0002) Taking cholesterol medication35% p=0.02) Without parental history of heart attack29% p=0.008) Not assigned to vitamin D29% p=0.02) With 2+ cardiovascular risk factors43% p=0.001) With baseline aspirin use36% p=0.007) With baseline statin use32% p=0.04) All-Cause Mortality African Americans with <1.5 servings of fish/wk36% p=0.03) Omega-3 vs. Placebo Post-Hoc Outcomes Death from Heart Attack50% p=0.04) Percutaneous coronary intervention (PCI; stent) 22% p=0.02) Coronary heart disease (heart attack, PCI, CVD death)17% p=0.02)